Disparities found in lung cancer care, survival in US versus England

May 1, 2018, Yale University
Lung CA seen on CXR. Credit: James Heilman, MD/Wikipedia

Despite steady declines in death rates in recent years, lung cancer remains the leading cause of cancer deaths in wealthy countries. In a new study, Yale researchers collaborated with investigators in Europe to examine lung cancer care and survival rates for patients with one of the most common forms of the disease.

Led by professor of medicine and of epidemiology Cary Gross, M.D., the global research team analyzed data on more than 170,000 older diagnosed with non-small cell in England and the United States between 2008 and 2012. They compared several aspects of cancer care and outcomes, including patient characteristics, stage of cancer at diagnosis, , and overall survival.

The research team found significant disparities in lung cancer care and survival between the two countries. In the United States, 25% of patients were diagnosed at the earliest stage of cancer compared with 15% of patients in England. Forty-five percent of U.S. patients were diagnosed late, at stage 4, versus 52% of their English counterparts.

Differences also emerged in treatment. Of U.S. patients diagnosed at stage 1, 60% had surgical treatment compared with only 55% of stage-1 patients in England.

These disparities from diagnosis through treatment appear to contribute to a substantial gap in overall survival rates, said the researchers. Two years after being diagnosed, 31% of U.S. lung cancer patients were still alive, while only 19% of English patients were, the researchers said.

"These findings—the first using age- and stage-specific, population-based data—show that lung cancer patients receive more active treatments and have better survival in the United States compared to England. Further work needs to be done to fully explain the reasons for this," said first author Anita Andreano of the University of Milan-Cicocco.

While the poorer lung cancer care outcomes in England are cause for concern, there's room for improvement on both sides of the Atlantic, said Gross, who is also a member of Yale Cancer Center. "This should be a call to action in both countries to learn how we could improve care and learn from each other's systems," he noted. "We need to share ideas and best practices, so we can continue to reduce tobacco use, implement effective lung screening programs, and ensure access to high-quality care."

Explore further: Treatment variations may be cutting short lives of lung cancer patients in England

More information: Anita Andreano et al, The Care and Outcomes of Older Persons with Lung Cancer in England and the United States, 2008-2012, Journal of Thoracic Oncology (2018). DOI: 10.1016/j.jtho.2018.04.022

Related Stories

Treatment variations may be cutting short lives of lung cancer patients in England

March 6, 2018
Differences in the active treatment of lung cancer across England may be cutting short the lives of hundreds of patients with the disease every year, concludes research published online in the journal Thorax.

Middle-aged more likely to be diagnosed with advanced lung cancer

June 13, 2016
Younger patients - aged 50 to 64 - are more likely to be diagnosed with late stage lung cancer than older patients according to new data being presented at the Cancer Outcomes and Data Conference in Manchester today.

Study uncovers healthcare disparities among octogenarians and nonagenarians with advanced lung cancer

January 8, 2018
A new study reveals that, among patients of advanced age with stage III lung cancer, African Americans and individuals who live in lower income areas are more likely to not receive any treatment. Published early online in ...

Cancer patients diagnosed early are more likely to avoid chemotherapy

October 26, 2017
Cancer patients are around five times more likely to have surgery to remove their tumour, and less likely to have chemotherapy, if they are diagnosed at the earliest stage compared to the latest stage, according to new figures.

Chemoradiation in elderly patients with stage III NSCLC improves overall survival

January 10, 2018
Elderly patients with stage III non-small cell lung cancer (NSCLC) showed improved overall survival (OS) when treated with chemoradiation (CRT) compared to definitive radiation (RT) alone.

Recommended for you

Mutant cells colonize our tissues over our lifetime

October 18, 2018
By the time we reach middle age, more than half of the oesophagus in healthy people has been taken over by cells carrying mutations in cancer genes, scientists have uncovered. By studying normal oesophagus tissue, scientists ...

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...

A 150-year-old drug might improve radiation therapy for cancer

October 17, 2018
A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer ...

Loss of protein p53 helps cancer cells multiply in 'unfavourable' conditions

October 17, 2018
Researchers have discovered a novel consequence of loss of the tumour protein p53 that promotes cancer development, according to new findings in eLife.

New method uses just a drop of blood to monitor lung cancer treatment

October 17, 2018
Dr. Tasuku Honjo won the 2018 Nobel Prize in physiology or medicine for discovering the immune T-cell protein PD-1. This discovery led to a set of anti-cancer medications called checkpoint inhibitors, one of the first of ...

Researcher fighting breast cancer with light therapy

October 17, 2018
When treatment is working for a patient who is fighting cancer, the light at the end of the tunnel is easier to see.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.